Evaluation of adult patients with hereditary spherocytosis

Intruduction: Hereditary spherocytosis (HS) is frequently diagnosed in the pediatric period. Therefore, studies on HS have often been conducted among pediatric patients, and there is no clear data on the disease in adulthood. Our aim was to reveal the follow-up findings of patients with adult HS and their geographic distribution in Turkey. Materials and Methods: The sample comprised 172 subjects with a HS diagnosis. Data collection commenced retrospectively in February 2004 and was completed by September 2020. Results: A total of 172 patients, 106 of whom were splenectomized and 66 of whom were non-splenectomized, were included in the study. Mean age of the entire group was 22.7 years. At the time of diagnosis, mean age of the entire group was 12.4 years; for splenectomized and non-splenectomized patients, it was 9.9 years and 16.6 years, respectively (p=0.000). At the time of diagnosis, anemia was more common in the splenectomized group (65.1%) than the non-splenectomized group (45.5%) (p=0.011). Thromboembolic event was not experienced in any patient after splenectomy. None of the patients in the splenectomized group was transfusion-dependent in their last visit, but in the non-splenectomized group, 6 patients (9.1%) were still transfusion-dependent (p=0.003). Conclusion: Anemia was more common finding at the time of diagnosis and the age at diagnosis was lower in the splenectomized patients. Transfusion-dependency had completely disappeared in splenectomized patients. HS was more frequently seen in the Black Sea, northern Central Anatolia, and northern Marmara regions than in other regions in Turkey.

Evaluation of adult patients with hereditary spherocytosis

Intruduction: Hereditary spherocytosis (HS) is frequently diagnosed in the pediatric period. Therefore, studies on HS have often been conducted among pediatric patients, and there is no clear data on the disease in adulthood. Our aim was to reveal the follow-up findings of patients with adult HS and their geographic distribution in Turkey. Materials and Methods: The sample comprised 172 subjects with a HS diagnosis. Data collection commenced retrospectively in February 2004 and was completed by September 2020. Results: A total of 172 patients, 106 of whom were splenectomized and 66 of whom were non-splenectomized, were included in the study. Mean age of the entire group was 22.7 years. At the time of diagnosis, mean age of the entire group was 12.4 years; for splenectomized and non-splenectomized patients, it was 9.9 years and 16.6 years, respectively (p=0.000). At the time of diagnosis, anemia was more common in the splenectomized group (65.1%) than the non-splenectomized group (45.5%) (p=0.011). Thromboembolic event was not experienced in any patient after splenectomy. None of the patients in the splenectomized group was transfusion-dependent in their last visit, but in the non-splenectomized group, 6 patients (9.1%) were still transfusion-dependent (p=0.003). Conclusion: Anemia was more common finding at the time of diagnosis and the age at diagnosis was lower in the splenectomized patients. Transfusion-dependency had completely disappeared in splenectomized patients. HS was more frequently seen in the Black Sea, northern Central Anatolia, and northern Marmara regions than in other regions in Turkey.

___

  • 1. Manciu S, Matei E, Trandafir B. Hereditary Spherocytosis - Diagnosis, Surgical Treatment and Outcomes. A Literature Review. Chirurgia (Bucharest, Romania : 1990). 2017;112(2):110-6.
  • 2. Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet (London, England). 2008;372(9647):1411-26.
  • 3. Bolton-Maggs PH. Hereditary spherocytosis; new guidelines. Archives of disease in childhood. 2004;89(9):809-12.
  • 4. Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King MJ, General Haematology Task Force of the British Committee for Standards in H. Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update. British journal of haematology. 2012;156(1):37-49.
  • 5. Oliveira MC, Fernandes RA, Rodrigues CL, Ribeiro DA, Giovanardi MF, Viana MB. Clinical course of 63 children with hereditary spherocytosis: a retrospective study. Rev Bras Hematol Hemoter. 2012;34(1):9-13.
  • 6. Christensen RD, Yaish HM, Gallagher PG. A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates. Pediatrics. 2015;135(6):1107-14.
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi-Cover
  • ISSN: 1300-6622
  • Yayın Aralığı: Yıllık
  • Başlangıç: 2015
  • Yayıncı: -
Sayıdaki Diğer Makaleler

Severe Immune Thrombocytopenia in Pregnancy Treated with Eltrombopag. A Case Report.

Serkan GÜVEN, Hakan AKTUNA, Seval AKPINAR, Burhan TURGUT

Marfan Sendromu Hastada Non-Koroner Sinüs Valsalvanın Dev Anevrizması

Yılmaz YOZGAT, Abdullah ERDEM, Amir AGHAYEV, Emre ÖTEYAKA, Gizem SARI, Mehmet Turan BASUNLU, Mustafa Özer ULUKAN, Atalay KARAKAYA, Murat UĞURLUCAN, Halil TÜRKOĞLU

Psöriatik Artrit Hastalarında Hastalık Şiddeti ile QT Dispersiyonu Arasındaki İlişki

Özgül SOYSAL GÜNDÜZ, Kezban ARMAĞAN ALPTÜRKER

Bebeklik dönemindeki kolik ağrıları ailesel Akdeniz Ateşini öngörebilir mi?

Özge ALTUĞ GÜCENMEZ

Evaluation of adult patients with hereditary spherocytosis

Emrah KILIÇASLAN, Selim SAYIN, Murat YILDIRIM, Tayfun ELİBOL, Hilmi Erdem GÖZDEN, Meltem AYLI, Muhammet Kürşat KAPTAN

Hüseyin ÖZKÖK, Mümtaz YILMAZ, Sait ŞEN, Aygül ÇELTİK, Banu SARSIK KUMBARACI, Meltem SEZİŞ DEMİRCİ, Gülay AŞÇI

COVID-19 SOKAĞA ÇIKMA KISITLAMASI SÜRESİNCE ÇOCUKLARDA YABANCI CİSİM ASPİRASYONLARI; YASAKLAR ÇOCUKLARA ZARARLI MI?

Sevim ÇAKAR, Gülin ERDEMİR EREN, Cahit Barış ERDUR, Kübra Evren ŞAHİN, Çiğdem Ömür ECEVİT, Özlem BEKEM

Koagülasyon Testlerinde Altı Sigma Yöntemi ve Değerlendirilmesi

Mert ÜĞE, Mehmet Hicri KÖSEOĞLU, Serap ÇUHADAR, Figen NARİN

Erişkinlerde serum kobalamin düzeyinin yüksekliği ileri tetkik veya takip gerektirir mi?

Işıl ERDOĞAN ÖZÜNAL, Taner TAN, Erman ÖZTÜRK

Yutma Fonksiyonunun Merkezi Kontrolü

Selen SEREL ARSLAN, Yağmur ELMALI